RCKTW (STOCKS)
Rocket Pharmaceuticals, Inc. Warrant
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 299
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $191.64M |
| Research and Development | $124.37M |
| Other Operating Expenses | $67.28M |
| Operating Income/Loss | -$191.64M |
| Income/Loss From Continuing Operations After Tax | -$17.25M |
| Income/Loss From Continuing Operations Before Tax | -$8.63M |
| Income Tax Expense/Benefit | $8.62M |
| Interest Expense, Operating | $1.89M |
| Net Income/Loss | -$17.25M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.25M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.25M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.16 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 224,286,178 |
| Diluted Average Shares | 226,124,508 |
| Assets | $423.10M |
| Current Assets | $289.55M |
| Cash | $283.70M |
| Other Current Assets | $5.85M |
| Noncurrent Assets | $133.55M |
| Fixed Assets | $25.10M |
| Intangible Assets | $25.15M |
| Other Non-current Assets | $83.30M |
| Liabilities | $54.27M |
| Current Liabilities | $31.32M |
| Wages | $7.07M |
| Other Current Liabilities | $24.25M |
| Noncurrent Liabilities | $22.95M |
| Equity | $368.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $368.83M |
| Liabilities And Equity | $423.10M |
| Net Cash Flow From Operating Activities | -$170.27M |
| Net Cash Flow From Operating Activities, Continuing | -$170.27M |
| Net Cash Flow From Investing Activities | $361.85M |
| Net Cash Flow From Investing Activities, Continuing | $361.85M |
| Net Cash Flow From Financing Activities | $82.00K |
| Net Cash Flow From Financing Activities, Continuing | $82.00K |
| Net Cash Flow | $191.66M |
| Net Cash Flow, Continuing | $191.66M |
| Comprehensive Income/Loss | -$17.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.25M |
| Other Comprehensive Income/Loss | -$17.25M |